plerixafor has been researched along with Waldenstrom Macroglobulinemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azab, AK; Azab, F; Burwick, N; Farag, M; Ghobrial, IM; Jia, X; Lee, J; Leleu, X; Melhem, M; Moreau, AS; Ngo, HT; Roccaro, A; Runnels, J; Sacco, A; Sackstein, R | 1 |
1 other study(ies) available for plerixafor and Waldenstrom Macroglobulinemia
Article | Year |
---|---|
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
Topics: Base Sequence; Benzylamines; Cell Adhesion; Cell Line; Cell Movement; Chemokine CXCL12; Cyclams; Endothelial Cells; Fibronectins; Heterocyclic Compounds; Humans; Integrin alpha4beta1; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Receptors, Chemokine; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Signal Transduction; Stromal Cells; Waldenstrom Macroglobulinemia | 2008 |